{"id":913,"date":"2019-10-16T05:55:33","date_gmt":"2019-10-16T04:55:33","guid":{"rendered":"http:\/\/therapeutic-impact.org\/?p=913"},"modified":"2019-10-16T05:55:35","modified_gmt":"2019-10-16T04:55:35","slug":"poitiers-une-avancee-majeure-face-au-cancer-du-pancreas-article-de-la-nouvelle-republique","status":"publish","type":"post","link":"https:\/\/therapeutic-impact.org\/?p=913","title":{"rendered":"Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique)"},"content":{"rendered":"\n<p>Voir article de la nouvelle r\u00e9publique:  <br><a href=\"https:\/\/www.lanouvellerepublique.fr\/poitiers\/poitiers-une-avancee-majeure-face-au-cancer-du-pancreas?fbclid=IwAR1n6CGnkZuMDDJG9z28UuC9HtaXz44nNOLDxEtMAyNLs703giMxJVJ2d10\">https:\/\/www.lanouvellerepublique.fr\/poitiers\/poitiers-une-avancee-majeure-face-au-cancer-du-pancreas?fbclid=IwAR1n6CGnkZuMDDJG9z28UuC9HtaXz44nNOLDxEtMAyNLs703giMxJVJ2d10<\/a><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Poitiers. La soci\u00e9t\u00e9 Seekyo et l\u2019\u00e9quipe de recherche de S\u00e9bastien Papot ont brevet\u00e9 un anticanc\u00e9reux. Les r\u00e9sultats exaltent les espoirs de la m\u00e9decine.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Le cancer du pancr\u00e9as\u00a0: 15.000\u00a0nouveaux cas par an. Une estimation inqui\u00e9tante, surtout lorsque l\u2019on constate sa progression fulgurante dans la soci\u00e9t\u00e9. Au point de parler d\u2019\u00e9pid\u00e9mie croissante.\u00a0<em>\u00ab\u00a0En 40\u00a0ans, on observe une multiplication par 6\u00a0des d\u00e9tections sans que l\u2019on ne puisse l\u2019expliquer<\/em>, confie le Pr S\u00e9bastien Papot, chercheur \u00e0 l\u2019Institut de chimie des milieux et mat\u00e9riaux de l\u2019universit\u00e9 de Poitiers (IC2MP).<em>\u00a0Certains \u00e9voquent les changements environnementaux entre pollution et alimentation.\u00a0\u00bb<\/em>\u00a0Toujours est-il que ce cancer demeure le plus agressif pour lequel les bonnes nouvelles sont rares dans l\u2019\u00e9volution des soins. Mais le professeur et sa soci\u00e9t\u00e9 Seekyo viennent de r\u00e9aliser de nouvelles avanc\u00e9es dans le traitement du cancer du pancr\u00e9as chez l\u2019adulte avec le d\u00e9p\u00f4t d\u2019un nouveau brevet en avril dernier. En somme, un nouvel espoir.<br>Avec de mauvais pronostics, c\u2019est \u00e0 petits pas que la m\u00e9decine devait appr\u00e9hender jusque-l\u00e0 les patients, notamment par le traitement classique \u2013 chirurgie, radioth\u00e9rapie et chimioth\u00e9rapie \u2013 d\u00e9contenanc\u00e9e par le faible taux de r\u00e9mission.\u00a0<em>\u00ab\u00a020\u00a0% des cas sont op\u00e9rables<\/em>, pr\u00e9cise S\u00e9bastien Papot.\u00a0<em>Et encore, quand la maladie est d\u00e9tect\u00e9e assez t\u00f4t, souvent par hasard.\u00a0\u00bb<\/em>\u00a0La survie moyenne ne d\u00e9passe pas les 12 mois.<\/p>\n\n\n\n<p><br>\u201c\u00a0M\u00e9dicament intelligent\u00a0\u201d\u00a0: une t\u00eate chercheuse<\/p>\n\n\n\n<p>La r\u00e9volution de Seekyo\u00a0: la vectorisation th\u00e9rapeutique.\u00a0<em>\u00ab\u00a0Nous passons par la cr\u00e9ation de nouvelles mol\u00e9cules anticanc\u00e9reuses capables de chercher, d\u00e9tecter et d\u00e9truire les tumeurs sans affecter les tissus sains.\u00a0\u00bb<\/em>\u00a0Ces vecteurs sont s\u00e9lectifs et con\u00e7us pour lib\u00e9rer de puissants agents anticanc\u00e9reux uniquement en pr\u00e9sence de la tumeur. En langue vernaculaire, on parle de\u00a0<em>\u00ab\u00a0m\u00e9dicament intelligent\u00a0\u00bb<\/em>. Une t\u00eate chercheuse dont les applications d\u00e9passeraient le cancer du pancr\u00e9as.<br>Si le professeur poitevin convoque toute la prudence \u2013\u00a0<em>\u00ab\u00a0Les espoirs meurent toujours en dernier\u00a0\u00bb<\/em>\u00a0\u2013 les r\u00e9sultats obtenus sur des mod\u00e8les de cancers humains (sein, cou et pancr\u00e9as donc), test\u00e9s sur des souris, sont plus que robustes.<\/p>\n\n\n\n<p><br>Sans effets secondaires<\/p>\n\n\n\n<p><em>\u00ab\u00a0La r\u00e9gression de la tumeur est totale et s\u2019inscrit dans la dur\u00e9e sur trois souris sur huit. Pour les cinq autres, l\u2019\u00e9tat est encourageant\u00a0\u00bb<\/em>, pr\u00e9cise le professeur. Avec un avantage majeur\u00a0: une efficacit\u00e9 certaine, sans effets secondaires alors que la chimioth\u00e9rapie classique butte encore face \u00e0 la montagne qu\u2019est le cancer du pancr\u00e9as. Mais il reste encore du chemin avant de confirmer ces r\u00e9sultats sur l\u2019\u00eatre humain. En pleine lev\u00e9e de fonds afin de poursuivre les tests,<em>\u00a0\u00ab\u00a0une mise sur le march\u00e9 pourrait prendre entre six et huit ans\u00a0\u00bb<\/em>.<\/p>\n\n\n\n<p><br><strong>La soci\u00e9t\u00e9 Seekyo, start-up fond\u00e9e en 2018, travaille en lien avec l\u2019universit\u00e9 de Poitiers et le CNRS et b\u00e9n\u00e9ficie d\u2019une aide de la Nouvelle-Aquitaine pour ses recherches th\u00e9rapeutiques sur le cancer.<\/strong><\/p>\n\n\n\n<p> <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Voir article de la nouvelle r\u00e9publique: https:\/\/www.lanouvellerepublique.fr\/poitiers\/poitiers-une-avancee-majeure-face-au-cancer-du-pancreas?fbclid=IwAR1n6CGnkZuMDDJG9z28UuC9HtaXz44nNOLDxEtMAyNLs703giMxJVJ2d10 Poitiers. La soci\u00e9t\u00e9 Seekyo et l\u2019\u00e9quipe de recherche de S\u00e9bastien Papot ont brevet\u00e9 [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[45],"tags":[],"class_list":["post-913","post","type-post","status-publish","format-standard","hentry","category-presse"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique) - Therapeutic Impact<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/therapeutic-impact.org\/?p=913\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique) - Therapeutic Impact\" \/>\n<meta property=\"og:description\" content=\"Voir article de la nouvelle r\u00e9publique: https:\/\/www.lanouvellerepublique.fr\/poitiers\/poitiers-une-avancee-majeure-face-au-cancer-du-pancreas?fbclid=IwAR1n6CGnkZuMDDJG9z28UuC9HtaXz44nNOLDxEtMAyNLs703giMxJVJ2d10 Poitiers. La soci\u00e9t\u00e9 Seekyo et l\u2019\u00e9quipe de recherche de S\u00e9bastien Papot ont brevet\u00e9 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/therapeutic-impact.org\/?p=913\" \/>\n<meta property=\"og:site_name\" content=\"Therapeutic Impact\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Therapeutic.IMPACT\/?fref=ts\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-16T04:55:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-10-16T04:55:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2016\/01\/logo-120.png\" \/>\n\t<meta property=\"og:image:width\" content=\"120\" \/>\n\t<meta property=\"og:image:height\" content=\"39\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ciriac Charles\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Therap_IMPACT\" \/>\n<meta name=\"twitter:site\" content=\"@Therap_IMPACT\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ciriac Charles\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/therapeutic-impact.org\/?p=913#article\",\"isPartOf\":{\"@id\":\"https:\/\/therapeutic-impact.org\/?p=913\"},\"author\":{\"name\":\"Ciriac Charles\",\"@id\":\"https:\/\/therapeutic-impact.org\/#\/schema\/person\/f774590f2a4d1e381706f8241b44c389\"},\"headline\":\"Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique)\",\"datePublished\":\"2019-10-16T04:55:33+00:00\",\"dateModified\":\"2019-10-16T04:55:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/therapeutic-impact.org\/?p=913\"},\"wordCount\":558,\"publisher\":{\"@id\":\"https:\/\/therapeutic-impact.org\/#organization\"},\"articleSection\":[\"Presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/therapeutic-impact.org\/?p=913\",\"url\":\"https:\/\/therapeutic-impact.org\/?p=913\",\"name\":\"Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique) - Therapeutic Impact\",\"isPartOf\":{\"@id\":\"https:\/\/therapeutic-impact.org\/#website\"},\"datePublished\":\"2019-10-16T04:55:33+00:00\",\"dateModified\":\"2019-10-16T04:55:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/therapeutic-impact.org\/?p=913#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/therapeutic-impact.org\/?p=913\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/therapeutic-impact.org\/?p=913#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/therapeutic-impact.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/therapeutic-impact.org\/#website\",\"url\":\"https:\/\/therapeutic-impact.org\/\",\"name\":\"Therapeutic Impact\",\"description\":\"from basic research to medicinal applications\",\"publisher\":{\"@id\":\"https:\/\/therapeutic-impact.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/therapeutic-impact.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/therapeutic-impact.org\/#organization\",\"name\":\"Therapeutic Impact\",\"url\":\"https:\/\/therapeutic-impact.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/therapeutic-impact.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2016\/01\/logo-120.png\",\"contentUrl\":\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2016\/01\/logo-120.png\",\"width\":120,\"height\":39,\"caption\":\"Therapeutic Impact\"},\"image\":{\"@id\":\"https:\/\/therapeutic-impact.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Therapeutic.IMPACT\/?fref=ts\",\"https:\/\/x.com\/Therap_IMPACT\",\"https:\/\/www.youtube.com\/channel\/UCBkbC8oHkDOTKqNHFKbTUMQ\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/therapeutic-impact.org\/#\/schema\/person\/f774590f2a4d1e381706f8241b44c389\",\"name\":\"Ciriac Charles\",\"url\":\"https:\/\/therapeutic-impact.org\/?author=7\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique) - Therapeutic Impact","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/therapeutic-impact.org\/?p=913","og_locale":"fr_FR","og_type":"article","og_title":"Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique) - Therapeutic Impact","og_description":"Voir article de la nouvelle r\u00e9publique: https:\/\/www.lanouvellerepublique.fr\/poitiers\/poitiers-une-avancee-majeure-face-au-cancer-du-pancreas?fbclid=IwAR1n6CGnkZuMDDJG9z28UuC9HtaXz44nNOLDxEtMAyNLs703giMxJVJ2d10 Poitiers. La soci\u00e9t\u00e9 Seekyo et l\u2019\u00e9quipe de recherche de S\u00e9bastien Papot ont brevet\u00e9 [&hellip;]","og_url":"https:\/\/therapeutic-impact.org\/?p=913","og_site_name":"Therapeutic Impact","article_publisher":"https:\/\/www.facebook.com\/Therapeutic.IMPACT\/?fref=ts","article_published_time":"2019-10-16T04:55:33+00:00","article_modified_time":"2019-10-16T04:55:35+00:00","og_image":[{"width":120,"height":39,"url":"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2016\/01\/logo-120.png","type":"image\/png"}],"author":"Ciriac Charles","twitter_card":"summary_large_image","twitter_creator":"@Therap_IMPACT","twitter_site":"@Therap_IMPACT","twitter_misc":{"\u00c9crit par":"Ciriac Charles","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/therapeutic-impact.org\/?p=913#article","isPartOf":{"@id":"https:\/\/therapeutic-impact.org\/?p=913"},"author":{"name":"Ciriac Charles","@id":"https:\/\/therapeutic-impact.org\/#\/schema\/person\/f774590f2a4d1e381706f8241b44c389"},"headline":"Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique)","datePublished":"2019-10-16T04:55:33+00:00","dateModified":"2019-10-16T04:55:35+00:00","mainEntityOfPage":{"@id":"https:\/\/therapeutic-impact.org\/?p=913"},"wordCount":558,"publisher":{"@id":"https:\/\/therapeutic-impact.org\/#organization"},"articleSection":["Presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/therapeutic-impact.org\/?p=913","url":"https:\/\/therapeutic-impact.org\/?p=913","name":"Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique) - Therapeutic Impact","isPartOf":{"@id":"https:\/\/therapeutic-impact.org\/#website"},"datePublished":"2019-10-16T04:55:33+00:00","dateModified":"2019-10-16T04:55:35+00:00","breadcrumb":{"@id":"https:\/\/therapeutic-impact.org\/?p=913#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/therapeutic-impact.org\/?p=913"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/therapeutic-impact.org\/?p=913#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/therapeutic-impact.org\/en\/"},{"@type":"ListItem","position":2,"name":"Poitiers : une avanc\u00e9e majeure face au cancer du pancr\u00e9as (article de la nouvelle r\u00e9publique)"}]},{"@type":"WebSite","@id":"https:\/\/therapeutic-impact.org\/#website","url":"https:\/\/therapeutic-impact.org\/","name":"Therapeutic Impact","description":"from basic research to medicinal applications","publisher":{"@id":"https:\/\/therapeutic-impact.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/therapeutic-impact.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/therapeutic-impact.org\/#organization","name":"Therapeutic Impact","url":"https:\/\/therapeutic-impact.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/therapeutic-impact.org\/#\/schema\/logo\/image\/","url":"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2016\/01\/logo-120.png","contentUrl":"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2016\/01\/logo-120.png","width":120,"height":39,"caption":"Therapeutic Impact"},"image":{"@id":"https:\/\/therapeutic-impact.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Therapeutic.IMPACT\/?fref=ts","https:\/\/x.com\/Therap_IMPACT","https:\/\/www.youtube.com\/channel\/UCBkbC8oHkDOTKqNHFKbTUMQ"]},{"@type":"Person","@id":"https:\/\/therapeutic-impact.org\/#\/schema\/person\/f774590f2a4d1e381706f8241b44c389","name":"Ciriac Charles","url":"https:\/\/therapeutic-impact.org\/?author=7"}]}},"_links":{"self":[{"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/posts\/913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=913"}],"version-history":[{"count":1,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/posts\/913\/revisions"}],"predecessor-version":[{"id":914,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/posts\/913\/revisions\/914"}],"wp:attachment":[{"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}